Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Evolving Landscape of Drug Therapies for Sickle Cell Disease

Hematology/Oncology Clinics of North America(2022)10.1016/j.hoc.2022.06.008Source: DataRank Database

The Evolving Landscape of Drug Therapies for Sickle Cell Disease is a research paper published in Hematology/Oncology Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

10 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.36)OA: closedTopics (37)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Payal Desai ORCID,Kenneth I. Ataga ORCID,Parul Rai ORCID

Live enrichment

PubMed:36400544 OpenAlex:https://openalex.org/W4309103911

U.S. Food and Drug Administration

Grant: R01FD006030

National Heart Lung and Blood Institute

Grant: HL159376

National Institutes of Health

FWCI

1.36

Citation Percentile

0.8%

Influential Citations

Citation Trend

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S0889858822000661

publisherhttps://api.elsevier.com/content/article/PII:S0889858822000661?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0889858822000661?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.hoc.2022.06.008

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36400544

Fields of Study

Hemoglobinopathies and Related DisordersAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentMedicineHumansAnemia, Sickle CellHydroxyureaHematopoietic Stem Cell TransplantationGenetic TherapyGlutamine

MeSH Terms

Anemia, Sickle CellGlutamineHumansHydroxyureaGenetic TherapyHematopoietic Stem Cell Transplantation

Keywords

MedicineDiseaseDrugIntensive care medicineHematopoietic stem cell transplantationClinical trialFood and drug administrationTransplantationHematopoietic stem cellStem cellBioinformaticsPharmacologyHaematopoiesisInternal medicineBiologyGeneticsTreatmentClinical TrialsDrug DevelopmentSickle Cell DiseaseDrug Therapies

Sustainable Development Goals

SDG 0: Good health and well-being